Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.

Simple item page
dc.contributor.authorSingh, Sandeepen_US
dc.contributor.authorGopal, Ajay Ken_US
dc.contributor.authorBahl, V Ken_US
dc.date.accessioned2005-05-04en_US
dc.date.accessioned2009-05-27T04:17:37Z
dc.date.available2005-05-04en_US
dc.date.available2009-05-27T04:17:37Z
dc.date.issued2005-05-04en_US
dc.identifier.citationSingh S, Gopal AK, Bahl VK. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence. Indian Heart Journal. 2005 May-Jun; 57(3): 201-9en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/2892
dc.language.isoengen_US
dc.source.urihttps://indianheartjournal.comen_US
dc.subject.meshAngina, Unstable --diagnosisen_US
dc.subject.meshAngioplasty, Transluminal, Percutaneous Coronary --methodsen_US
dc.subject.meshCombined Modality Therapyen_US
dc.subject.meshElectrocardiographyen_US
dc.subject.meshEmergency Treatmenten_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMyocardial Infarction --diagnosisen_US
dc.subject.meshPlatelet Aggregation Inhibitors --administration & dosageen_US
dc.subject.meshPlatelet Glycoprotein GPIIb-IIIa Complex --antagonists & inhibitorsen_US
dc.subject.meshPrognosisen_US
dc.subject.meshRandomized Controlled Trials as Topicen_US
dc.subject.meshRisk Assessmenten_US
dc.subject.meshSensitivity and Specificityen_US
dc.subject.meshSurvival Analysisen_US
dc.subject.meshThrombolytic Therapy --methodsen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleGlycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.en_US
dc.typeComparative Studyen_US
dc.typeEditorialen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Heart Journal